Overview
Location
United States, California, San Diego
Employees
11-50
Founded date
2020
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 23, 2022 | Ocelot Bio gets a cool $36M series A and a new CEO to boot | With a new CEO and a phase 2 trial ready to go, Ocelot Bio has snagged $36 million in a series A financing led by RA Capital Management, Venrock and Vivo Capital. The funding will go toward a phase 2 trial for Ocelot’s OCE-205, which is und... |
| Mar 23, 2022 | Ocelot Bio Gets a Cool $36M Series A and a New CEO to... | |
| Ocelot Bio | “Ocelot Bio is a clinical-stage biopharmaceutical company dedicated to bringing meaningful therapeutic interventions to patients in dire need due to complications of decompensated (advanced) cirrhosis.” |
Reviews 0
FAQ about Ocelot Bio
When was Ocelot Bio founded?
Ocelot Bio was founded in 2020.
What has the press written about Ocelot Bio?
Parsers VC has collected 4 articles mentioning Ocelot Bio, among them “Ocelot Bio gets a cool $36M series A and a new CEO to boot” (Mar 23, 2022) and “Ocelot Bio Gets a Cool $36M Series A and a New CEO to...” (Mar 23, 2022).
Is Ocelot Bio still active?
Yes, Ocelot Bio is active; its latest activity on Parsers VC dates from Mar 23, 2022.